ESC Premium Access

Intensive platelet inhibition - Have we reached the ceiling or are there options for further development?

logo

Congress Presentation

About the speakers

Professor Lars Wallentin

Uppsala University, Uppsala (Sweden)
18 presentations
1 follower

Professor Robert Storey

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
23 presentations
1 follower

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)
38 presentations
0 follower

Professor Stefan James

Uppsala University, Uppsala (Sweden)
45 presentations
2 followers

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
46 presentations
12 followers

5 more presentations in this session

Welcome and Introduction

Speaker: Professor L. Wallentin (Uppsala, SE)

Thumbnail

Manipulating the platelet - Successes and failures

Speaker: Professor R. Storey (Sheffield, GB)

Thumbnail

Changing clinical outcomes with more intensive platelet inhibition

Speaker: Professor C. Cannon (Boston, US)

Thumbnail

Effects in various clinical settings, patient subsets and healthcare realities

Speaker: Professor S. James (Uppsala, SE)

Thumbnail

Summary and close

Speaker: Professor R. Mehran (New York, US)

Thumbnail

Access the full session

Intensive platelet inhibition in acute coronary syndromes - Where are we a decade after PLATO study results? (EBAC Accredited)

Speakers: Professor L. Wallentin, Professor R. Storey, Professor C. Cannon, Professor S. James, Professor R. Mehran...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb